
EyePoint Pharmaceuticals Grants Stock Options to New Employees

EyePoint Pharmaceuticals Inc. has granted non-statutory stock options to seven new employees as inducement awards. The options cover 31,000 shares at an exercise price of $11.58 per share, with a ten-year term. Vesting occurs over four years, with 25% after one year and the rest monthly over three years, contingent on continued employment. This announcement was made on November 17, 2025.
EyePoint Pharmaceuticals Inc. has granted non-statutory stock options to seven new employees as part of inducement awards. The company issued options to purchase a total of 31,000 shares of common stock at an exercise price of $11.58 per share, reflecting the closing price on November 14, 2025. Each option has a ten-year term and will vest over four years, with 25% vesting after one year and the remainder vesting in equal monthly installments over the following three years, contingent on continued employment. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. EyePoint Pharmaceuticals Inc. published the original content used to generate this news brief on November 17, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here

